Biochemical assessment of metabolic associated fatty liver disease
Metabolic-associated fatty liver disease (MAFLD) is defined as fat accumulation in the liver in the presence of metabolic alterations. This disorder is generally asymptomatic and may progress to severe liver disease, which are linked to inflammation and/or fibrosis. MAFLD has a high prevalence (26%)...
Main Authors: | Guerra-Ruiz Armando R., Casals Gregori, Iruzubieta Paula, Lalana Marta, Leis Alba, López Rosa María, Crespo Javier, Morales-Ruiz Manuel |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2021-03-01
|
Series: | Advances in Laboratory Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1515/almed-2021-0009 |
Similar Items
-
Autophagy: a new target for nonalcoholic fatty liver disease therapy
by: Mao YQ, et al.
Published: (2016-03-01) -
Stratification by Non-invasive Biomarkers of Non-alcoholic Fatty Liver Disease in Children
by: Yiyoung Kwon, et al.
Published: (2022-04-01) -
Double Trouble: How Microbiome Dysbiosis and Mitochondrial Dysfunction Drive Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
by: Wesam Bahitham, et al.
Published: (2024-02-01) -
Association of Inflammatory Cytokines With Non-Alcoholic Fatty Liver Disease
by: Yamei Duan, et al.
Published: (2022-05-01) -
Multinodular fatty liver after herpes-zoster vaccine: Case report and review of the literature
by: Michael Shim, et al.
Published: (2008-10-01)